Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters

MLA

Kenta Watanabe, et al. “Radiation Pneumonitis after Definitive Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Non‐small Cell Lung Cancer: Analysis of Dose‐volume Parameters.” Cancer Medicine, vol. 9, no. 13, July 2020, pp. 4540–49. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5d86e338a3e0e2c0afecb73cce0955e9&authtype=sso&custid=ns315887.

APA

Kenta Watanabe, Norihisa Katayama, Takao Hiraki, Shinichi Toyooka, Susumu Kanazawa, Yoshinobu Maeda, Masahiro Kuroda, Takeshi Ogata, Kuniaki Katsui, & Katsuyuki Kiura. (2020). Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters. Cancer Medicine, 9(13), 4540–4549.

Chicago

Kenta Watanabe, Norihisa Katayama, Takao Hiraki, Shinichi Toyooka, Susumu Kanazawa, Yoshinobu Maeda, Masahiro Kuroda, Takeshi Ogata, Kuniaki Katsui, and Katsuyuki Kiura. 2020. “Radiation Pneumonitis after Definitive Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Non‐small Cell Lung Cancer: Analysis of Dose‐volume Parameters.” Cancer Medicine 9 (13): 4540–49. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5d86e338a3e0e2c0afecb73cce0955e9&authtype=sso&custid=ns315887.